Maria Bodnar is a retired nurse, living in Victoria Australia with her husband. In 2013 Maria went in for her routine Breast Screen test and the following day she received a call from one of the nurses asking her to come in so they could review her results, and Maria knew it was breast cancer.

Maria is a participant in the TUGETHER clinical trial, which aims to find out if adding tucatinib and pembrolizumab to the usual treatment given to people with advanced (metastatic) HER2-positive breast cancer, slows down the growth of the cancer. We spoke to Maria about her diagnosis and her decision to participate in a clinical trial.